S. Chittmittraprap

Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy

Natthaya Chuaypen, Nawarat Posuwan, S. Chittmittraprap et al. · Clinical Microbiology and Infection · 2017 · 55 citations

Pharmacy, Immunology, Pharmacology +13

A randomized clinical trial of peginterferon alpha‐2b with or without entecavir in patients with <scp>HB</scp>eAg‐negative chronic hepatitis B: Role of host and viral factors associated with treatment response

Pisit Tangkijvanich, S. Chittmittraprap, Kittiyod Poovorawan et al. · Journal of Viral Hepatitis · 2015 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Serum <i>Wisteria floribunda</i> agglutinin‐positive Mac‐2 binding protein level as a diagnostic marker of hepatitis B virus‐related hepatocellular carcinoma

Natthaya Chuaypen, S. Chittmittraprap, Nutcha Pinjaroen et al. · Hepatology Research · 2018 · 18 citations

Medicine, Oncology, Pathology +17

Association of Vitamin-D-Related Genetic Variations and Treatment Response to Pegylated Interferon in Patients with Chronic Hepatitis B

Umaporn Limothai, Natthaya Chuaypen, Apichaya Khlaiphuengsin et al. · Antiviral Therapy · 2016 · 13 citations

Pharmacy, Genetics, Molecular Genetics +17